BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16597856)

  • 1. Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas.
    Kraus I; Molden T; Holm R; Lie AK; Karlsen F; Kristensen GB; Skomedal H
    J Clin Microbiol; 2006 Apr; 44(4):1310-7. PubMed ID: 16597856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women >30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion.
    Molden T; Kraus I; Karlsen F; Skomedal H; Nygård JF; Hagmar B
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):367-72. PubMed ID: 15734959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses.
    Molden T; Kraus I; Skomedal H; Nordstrøm T; Karlsen F
    J Virol Methods; 2007 Jun; 142(1-2):204-12. PubMed ID: 17379322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer.
    Ratnam S; Coutlee F; Fontaine D; Bentley J; Escott N; Ghatage P; Gadag V; Holloway G; Bartellas E; Kum N; Giede C; Lear A
    J Clin Microbiol; 2010 Aug; 48(8):2779-85. PubMed ID: 20573862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: diagnostic and prognostic implications.
    Varnai AD; Bollmann M; Bankfalvi A; Speich N; Schmitt C; Griefingholt H; Kovács K; Klozoris C; Bollmann R
    Oncol Rep; 2008 Feb; 19(2):457-65. PubMed ID: 18202795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of HPV detection technologies: Hybrid capture 2, PreTect HPV-Proofer and analysis of HPV DNA viral load in HPV16, HPV18 and HPV33 E6/E7 mRNA positive specimens.
    Keegan H; Mc Inerney J; Pilkington L; Grønn P; Silva I; Karlsen F; Bolger N; Logan C; Furuberg L; O'Leary J; Martin C
    J Virol Methods; 2009 Jan; 155(1):61-6. PubMed ID: 18955086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitous presence of E6 and E7 transcripts in human papillomavirus-positive cervical carcinomas regardless of its type.
    Nakagawa S; Yoshikawa H; Yasugi T; Kimura M; Kawana K; Matsumoto K; Yamada M; Onda T; Taketani Y
    J Med Virol; 2000 Oct; 62(2):251-8. PubMed ID: 11002256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
    Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
    Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.
    Bishop JA; Ma XJ; Wang H; Luo Y; Illei PB; Begum S; Taube JM; Koch WM; Westra WH
    Am J Surg Pathol; 2012 Dec; 36(12):1874-82. PubMed ID: 23060353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear.
    Molden T; Nygård JF; Kraus I; Karlsen F; Nygård M; Skare GB; Skomedal H; Thoresen SO; Hagmar B
    Int J Cancer; 2005 May; 114(6):973-6. PubMed ID: 15645423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.
    Duvlis S; Popovska-Jankovic K; Arsova ZS; Memeti S; Popeska Z; Plaseska-Karanfilska D
    J Med Virol; 2015 Sep; 87(9):1578-86. PubMed ID: 25880030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of E6/E7 mRNA from 'high risk' human papillomavirus in relation to CIN grade, viral load and p16INK4a.
    Andersson S; Hansson B; Norman I; Gaberi V; Mints M; Hjerpe A; Karlsen F; Johansson B
    Int J Oncol; 2006 Sep; 29(3):705-11. PubMed ID: 16865288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
    Han L; Husaiyin S; Zhao F; Rezhake R; Niyazi M
    Clin Lab; 2018 Sep; 64(9):1363-1371. PubMed ID: 30274003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA.
    Coquillard G; Palao B; Patterson BK
    Gynecol Oncol; 2011 Jan; 120(1):89-93. PubMed ID: 20950847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction.
    Sotlar K; Stubner A; Diemer D; Menton S; Menton M; Dietz K; Wallwiener D; Kandolf R; Bültmann B
    J Med Virol; 2004 Sep; 74(1):107-16. PubMed ID: 15258976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix.
    Cattani P; Zannoni GF; Ricci C; D'Onghia S; Trivellizzi IN; Di Franco A; Vellone VG; Durante M; Fadda G; Scambia G; Capelli G; De Vincenzo R
    J Clin Microbiol; 2009 Dec; 47(12):3895-901. PubMed ID: 19828739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of mRNA E6/E7 HPV high oncogenic risk expression in colposcopy of cervical intraepithelial neoplasia (CIN).
    Galarowicz B; Jach R; Kidzierska J; Dyduch G; Zajac K; Pityński K; Banaś T; Huras H; Streb J; Dulińska-Litewka J; Hosiawa V; Juszczak M; Milewicz T
    Przegl Lek; 2012; 69(9):651-7. PubMed ID: 23401983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
    Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
    Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears.
    Ren C; Zhu Y; Yang L; Zhang X; Liu L; Ren C
    Arch Gynecol Obstet; 2018 Feb; 297(2):425-432. PubMed ID: 29143102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.